Trade Summary

6 days ago, Bancel Stephane, serving as Chief Executive Officer at Moderna, Inc. (MRNA), sold 499,246 shares at $57.52 per share, for a total transaction value of $28,715,011.49. Following this transaction, Bancel Stephane now holds 6,187,791 shares of MRNA.

This sale represents a 7.47% decrease in Bancel Stephane's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 4:11 PM ET, 2 days after the trade was made.

Moderna, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.